iS Clinical affiliate program
Join an Autism clinical trial today and take a step toward finding a better solution for you. Your child may qualify to participate if they have been diagnosed with Autism. Study Description: The purpose of this clinical study is to see if the investigational drug is effective at helping to reduce symptoms of irritability associated with autism spectrum disorder in children. The study medication is currently FDA approved to treat several other psychiatric conditions in adults and is being tested as a potential new psychiatric therapy option for children with autism spectrum disorder. You and your child may be asked to attend at least one screening visit to determine if your child is eligible to enroll in the study. If enrolled, your child will receive either the drug being tested in this study or a placebo to be taken once daily for 2 months. Total participation will last approximately 5 months and you and your child will be asked to attend 9 office visits. During these visits, your child will complete various assessments and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
All your affiliate program data in one place
One dashboard to track Transactions - Revenues - Clicks - Payments with Strackr.com
Try for free
Clinical Supplies USA is the largest retailer of American made PPE and N95 masks. They have a variety of 3M, Honeywell, and other American-made products in stock that ship same day. They are trusted across the US for their impeccable service and quality goods. Their stellar reputation has provided us with the opportunity to serve countless individuals, governments, schools, and Fortune 500 Companies. This program offers 15-day cookie duration period.
Those who qualify to be part of this high cholesterol study may receive up to $1,000 for their participation, as well as no-cost study medication and no-cost study-related care from a local doctor.
With Acurian Health, customers who suffer from asthma can participate in a clinical trial that will provide them with study medication and care at no cost to them, as well as financial compensation for their volunteering.
US Doctors Clinical provides high-quality products, doctor-formulated, clinically proven and condition-specific, that are not only good users but also delivers real results to help reach health and vitality goals. This program offers a 60-day cookie duration.
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Doctor must have already diagnosed you with asthma for at least one year - Must currently use a daily inhaler that contains a corticosteroid? Examples include: Flovent HFA, Pulmicort, Qvar, Advair, Breo, Dulera, Azmacort. Rescue inhalers such as albuterol should not be counted. - In the past year, must have had an asthma exacerbation (a worsening of symptoms) that required: Treatment with systemic (oral, IV, injectable) corticosteroids for at least 3 days or Led to an emergency room/urgent care visit or hospitalization - Cannot also be diagnosed with the following: Cystic fibrosis, Pulmonary fibrosis, Chronic obstructive pulmonary disease (COPD), Emphysema - Cannot currently smoke Study Description: The purpose of this clinical study is to test if the use of an approved asthma medication, dupilumab, can preserve long term lung function in people with moderate to severe asthma. If you are eligible, you will be asked to attend a screening visit to determine if you can enroll in the study. If enrolled, you will receive either dupilumab or placebo to be given as an injection once every 2 weeks for 3 years. You will have a 2:1 chance of being assigned dupilumab versus the placebo. The study medication will be given alongside current standard of care asthma therapy. Your total participation will last approximately 3 years and 4 months and you will be asked to attend 15 doctor’s visits. During these visits, you will complete various diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel.
Conversion Point: Valid Form Fill Ages: 6-11 Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $675 for their time and reimbursed for travel expenses.. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Child must be between the ages of 6-11 years old - At least 10% of child's body must be affected with eczema (that is approximately the surface of one entire arm (front and back)) - Child cannot have taken Adbry (tralokinumab) within the last 4 months - Child cannot be currently receiving allergy shots - Child cannot have asthma Study Description: The purpose of this clinical study is to see how effective an investigational injectable medication is at helping to treat moderate to severe atopic dermatitis (eczema) in children and adolescents. You and your child will be asked to attend up to 2 screening visits to determine if they are eligible to enroll in the study. As part of the screening process, all participants will be instructed to use a topical corticosteroid (TCS) on areas affected by eczema, once daily, for 2 weeks. If eligible to participate, your child will receive injections of either the study drug or a placebo every 2 to 4 weeks while continuing to apply the steroid cream. Your child’s total participation will last approximately 8 months and you and your child will be asked to attend 10 further doctor’s visits. During these visits, he/she will complete various diagnostic and laboratory tests. After completing the study’s treatment period, your child may be eligible to partake in an open-label study, in which all participants receive the study medication. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $675 for their time and reimbursed for travel expenses. The doctor’s office conducting the study will be able to provide you and your child with more information about the study requirements.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Patient Profile / Filters: Gender: Any Ages: 18+ Study Description: A research study is looking to test the safety and effectiveness of an investigational medication for the treatment of Clostridioides difficile infection, also known as C. Diff infection or CDI. You may be eligible to participate immediately if you currently have active symptoms of C. Diff infection (diarrhea three or more times a day).
Conversion Point: Valid Form Fill Age Range: 16-40 Gender: Women Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1,842 for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - You (or your child) cannot have been diagnosed with a confirmed or suspected immunosuppressive or immunodeficient conditions – these include B cell deficiency, T cell deficiency, and HIV - Cannot have been diagnosed with an autoimmune disorder, including: o Crohn’s disease o Ulcerative colitis o Lupus o Type 1 Diabetes o Multiple Sclerosis o Rheumatoid Arthritis o Psoriasis - You (or your child) cannot have used an oral immunosuppressant such as prednisone for 14 consecutive days or longer in the last six months - Cannot have received any blood products in last three months - This study requires all participants to use a highly effective form of birth control for the first 9 months of study participation. Would you (would your child) be willing to avoid pregnancy by using either hormonal contraception or sexual abstinence? Study Description" The purpose of this clinical study is to see how effective an investigational vaccine is at preventing Cytomegalovirus (CMV) infection. You (your child) may be asked to attend 1 screening visit to determine if you (they) are eligible to enroll in the study. If enrolled, you (your child) will receive either the investigational vaccine being tested in this study or a placebo as 3 doses over 6 months. Your (your child’s) total participation will last approximately 2.5 years and you (they) will be asked to attend 13 doctor’s visits and at least 5 phone visits. During these visits, you (they) will complete various diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1,842 for time and travel.
Conversion Point: Valid Form Fill Age Range: 40-99 Gender: Any Reach: 30% of the US population Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $85 per visit for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must be diagnosed with COPD and chronic bronchitis for one year or longer - Must be treating your COPD using regular maintenance triple therapy (an inhaled corticosteroid (ICS), an inhaled LABA (a type of bronchodilator), and an inhaled LAMA (a type of bronchodilator) - Must have experienced a COPD exacerbation within the past year that required you to visit an ER and/or receive treatment with steroids or antibiotics - For current or former smokers - Cannot have a history of the following lung diseases: pulmonary fibrosis, cystic fibrosis, alpha 1 anti-trypsin deficiency, interstitial lung disease Study Description: This is a clinical research study to test the safety and effectiveness of an investigational medication as an add-on treatment for Chronic Obstructive Pulmonary Disease (COPD). You may qualify to participate if you have been diagnosed with COPD, are currently prescribed triple maintenance therapy and have had at least one exacerbation in the past year. You may be asked to attend up to two screening visits to determine if you are eligible to enroll in the study. If enrolled, you will be randomly selected to receive either the investigational medication, an approved oral medication (known as roflumilast, marketed as Daliresp), or a placebo to be taken daily for one year. Study-provided medication will be taken alongside your current triple COPD medications and rescue therapy will be available as needed. Your total participation will last just over 1 year (56 weeks), and you will be asked to complete 2 phone calls and attend up to 8 doctor's visits throughout the study. You will complete various diagnostic and laboratory tests during your visits, and you will be asked to complete daily questionnaires in an e-diary to evaluate your COPD symptoms. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $85 per visit for time and travel.
Description: Find paid clinical trials in your area with CareHealth, offering access to new treatments and potential compensation.
Requirement: SOI
Country(ies): US
Media: Blog, Display, Newsletter, Search, Social, Text
Restrictions: No Incentives
Other: None.
Clinical Innovation tilbyder kvalitetsprodukter til træning, restitution og behandling. Sortimentet dækker bl.a. bandager, indlæg, træningsudstyr og løsninger til hjemmebehandling. Professionel affiliate management ved affiliatemanager.dk.
Description: Get a chance to participate in a Free Clinical Research Opportunity & get a compensation up to $700 for sharing your thoughts and opinions!!
Requirement: Prescreener + Registration
Country(ies): US (select zips)
Media: Display, Incent, Newsletter, Search, Social, Text
Restrictions: None
Incidence Rate: COPD affects about 12 million adults in the US; 3rd leading cause of death in US (more than 120k yearly)
Gender: Men and Women
Age Range: 18+
Other: Must have been diagnosed with chronic obstructive pulmonary disease (COPD). Reports duration of at least a year. Reports history of exacerbation. Reports smoking history of at least ten pack-years. Not open nationwide, contact Affiliate Manager for zip code list in select states. For qualified lead, the data including phone number must be valid as the client has a call center to validate the leads.
Description: Get a chance to participate in a Free Clinical Research Opportunity & get investigational drug, study-related care and compensation for time and travel for sharing your thoughts and opinions!!
Requirement: Screener + Registration
Country(ies): US (select zips)
Media: Display, Incentivized, Newsletter, Search, Text Links
Restrictions: None
Gender: Male and Female
Age Range: 18+
Other: Specifically looking for people with COVID-19 Positive tests within the last 9 days. Not open nationwide, contact Affiliate Manager for zip code list in select states. For qualified lead, the data including phone number must be valid as the client has a call center to validate the leads.
Description: Get a chance to participate in a Free Clinical Research Opportunity & get investigational drug, study-related care and compensation for time and travel for sharing your thoughts and opinions!!
Requirement: Screener + Registration
Country(ies): US (select zips)
Media: Blog, Display, Incent, Newsletter, Search, Social, Text
Restrictions: Use of non-approved creative
Gender: Male and Female
Age Range: 65+
Other: The patient profile includes healthy adult participants aged 50 or older who have not received a COVID-19 vaccine or booster in the past 3 months, have not been diagnosed with the flu or received a flu shot in the past 5 months, and have not received Tamiflu or other antivirals in the past 5 months. Not open nationwide, contact Affiliate Manager for zip code list in select states. For qualified lead, the data including phone number must be valid as the client has a call center to validate the leads.
Description: Get a chance to participate in a Free Clinical Research Opportunity & get investigational drug, study-related care and compensation for time and travel for sharing your thoughts and opinions!!
Requirement: Screener + Registration
Country(ies): US (select zips)
Media: Display, Incentivized, Newsletter, Search, Text Links
Restrictions: None
Gender: Male and Female
Age Range: 18+
Other: The end users must have diabetes and have been diagnosed with Diabetic Peripheral Neropathy (DPN) in both feet. Has moderate to severe foot pain for more than 6 months. Should have BMI < 40. Not open nationwide, contact Affiliate Manager for zip code list in select states. For qualified lead, the data including phone number must be valid as the client has a call center to validate the leads.
Description: Get a chance to participate in a Free Clinical Research Opportunity & get compensation up to $350 for sharing your thoughts and opinions.
Requirement: Screener + Registration
Country(ies): US (select zips)
Media: Display, Incentivized, Newsletter, Search, Text Links
Restrictions: None
Incidence Rate: Unknown, Estimates from approximately 4 million US adults have been reported to have diagnosed with Fibromyalgia. Fibromyalgia can affect people of all ages, including children. However, most people are diagnosed during middle age and are more likely to have fibromyalgia as they get older. If you have lupus or rheumatoid arthritis (RA), you are more likely to develop fibromyalgia.
Gender: Men and Women
Age Range: 18-75
Other: Reports Fibromyalgia for > 1 year; DENIES confounding pain conditions like DPN, DENIES concomitant inflammatory disorders like RA and Lupus. Active symptoms: pain all over the body (also referred to as widespread pain), sleep problems, fatigue, and often emotional and mental distress. Not open nationwide, contact Affiliate Manager for zip code list. For qualified lead, the data including phone number must be valid as the client has a call center to validate the leads.
Description: Are you or a loved one healthy and age 18 or older? If so, you may qualify for research studies on Flu vaccine. Be part of studies enrolling now in your city. Qualified participants may receive payment up to $725, which varies by study.
Requirement: Screener + Registration
Country(ies): US (select zips)
Media: Display, Incentivized, Newsletter, Search, Text Links
Restrictions: No brokering
Other: Open to Healthy adults age 18+ who have not had the 2021-2022 seasonal flu vaccine in the 6 months prior to screening. No vaccines 4 weeks before receiving study vaccine. Ask your affiliate manager for the zip code list
Description: Get a chance to participate in a Free Clinical Research Opportunity & get a compensation which varies by study up to $500 for sharing your thoughts and opinions!!
Requirement: Screener + Registration
Country(ies): US (select zips)
Media: Display, Email, Incentivized, Newsletter, Search, Text Links
Restrictions: None
Incidence Rate: Depression is a mental health disorder characterized by persistently depressed mood or loss of interest in daily activities. More than 3 million adults suffer from depression in the US.
Gender: Men and Women
Age Range: 18-74
Other: Reports diagnosed depression and current depressive episode. Reports 1-2 prescription antidepressants during current episode, reports current SSRI or SNRI therapy, denies that current antidepressant is first lifetime antidepressant. Not open nationwide, contact Affiliate Manager for zip code list. For qualified lead, the data including phone number must be valid as the client has a call center to validate the leads.
Description: When a virus is incurable, a vaccine may be the answer. Help fight RSV if you're 60+. Earn up to $1,025, varies by study.
Requirement: Screener + Registration
Country(ies): US (select zips)
Media: Display, Incentivized, Newsletter, Search, Text Links
Restrictions: None
Gender: Male and Female
Age Range: 60+
Other: Not open nationwide, contact Affiliate Manager for zip code list in select states. For qualified lead, the data including phone number must be valid as the client has a call center to validate the leads.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: Diagnosed with Type 2 Diabetes Cannot be receiving dialysis Cannot have a history of heart or liver failure Cannot be on blood thinners Diabetic kidney disease (diabetic nephropathy) is a common complication of type 1 and type 2 diabetes. Over time, poorly controlled diabetes can cause damage to blood vessel clusters in your kidneys that filter waste from your blood. This can lead to kidney damage and cause high blood pressure. Study Description: The purpose of this clinical study is to see how effective an investigational injectable cell therapy is at helping to treat diabetic kidney disease. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will be randomly assigned to one of two groups. One group will undergo a kidney biopsy. The study team will prepare the investigational product from the biopsy tissue. You will then receive one injection of your own highly concentrated kidney cells into each kidney, three months apart. The second group will undergo simulated procedures for the biopsy and the injections, meaning that the procedure will be mimicked, but no actual tissue is extracted and reinjected. You will not know which group you are in while participating in the study. Your total participation may last up to 5 years. You will be asked to attend 16 office visits in the first 6 months and then follow-up visits every 3 months until the study ends. During these visits, you will complete various procedures, diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1575 for 7 visits or $2475 for 11 visits for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must currently have an active eczema rash on your face - Eczema rash must affect your eyes or eyelids - if eligible to participate, you will be asked to discontinue wearing contact lenses for the duration of the study Study Description: The purpose of this clinical study is to see how effective an investigational medication is at helping to treat a condition known as atopic keratoconjunctivitis, or AKC. AKC presents as red, itchy eyes and eye lids and is commonly seen in patients with facial eczema that affects the eyes and/or eye lids. The study medication is currently FDA approved to treat several inflammatory conditions and is being explored as a new therapy option for patients with AKC. You will be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the injectable medication being tested in this study or a placebo to be administered every 7 days for a total of 16 weeks of treatment. Your total participation will last approximately 4 months and you will be asked to attend 7 doctor’s visits. After 4 months, participants will be offered the chance to join an optional open-label period where they will receive the study medication for up to an additional 16 weeks of treatment. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1575 for 7 visits or $2475 for 11 visits for time and travel. During study visits, you will complete various procedures and tests that will include visual tests, eye exams, vitals, and physical exams. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1250 for your participation, time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must have had one of the following: A: Heart attack B: Heart revascularization procedure C: Stroke D: Carotid artery (neck) revascularization procedure E: Peripheral artery (leg) revascularization procedure F: Lower leg amputation due to peripheral artery disease - Must be taking medications to lower your cholesterol or lipid levels
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $50 per visit for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must be diagnosed with high blood pressure by your doctor for at least 6 months - Your blood pressure must be high even when taking your medication Study Description: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat high blood pressure. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken once daily for approximately 3 months. You will be required to take a standardized regimen of anti-hypertension medication as directed by the study physician alongside the study drug or placebo. Total participation could last up to 19 weeks, and you may be asked to attend 9 doctor’s visits. During these visits, you will complete various diagnostic and laboratory tests. Following the initial 3-month treatment period, you may be given the option to enter an open label extension period where all participants will receive the study drug. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $50 per visit for time and travel. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages:18-75 Gender: All Study Description: The purpose of this clinical study is to determine whether an investigational oral medication can help to treat hypothyroidism. You may qualify to participate if you are currently taking the medication levothyroxine. If enrolled, you will be randomly selected to receive either the medication being tested in this study or an FDA approved thyroid medication to be taken once a day for up to 7 months (30 weeks). Total participation will last approximately 10 months (42 weeks) and you will be required to attend doctor’s visits every 6 weeks throughout the study. At the end of the 7-month treatment period, you will have the option to enroll in an open label extension period where you would take the study medication for up to 6 additional months. The doctor’s office conducting the study will be able to provide you with more information about the study requirements and you can discuss the optional extension if you have any questions. Trial-related procedures, study medication and transportation expenses will be covered at no cost to you. - Must have a diagnosis of hypothyroidism and be taking medication as thyroid replacement therapy for 6 months or longer - Cannot have had thyroid surgery within the last year - Cannot have had your thyroid removed - Cannot have had thyroid cancer or gastric bypass surgery or gastric sleeve surgery
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Age Range: 40-80 Gender: All Study Description: The TemPo studies are evaluating the efficacy and safety of an investigational drug for Parkinson’s Disease. If you are interested in participating, you will be asked to attend a screening visit to determine your eligibility to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken once daily for 6 months, alongside your current medication (if any). Following the Study Treatment Period, you will have the option to participate in an Open-label Extension Study where you are guaranteed to receive the active study drug. Total study duration, (not including the Open Label Extension Period), is approximately 27 weeks with 12 office visits. The doctor’s office conducting the study will be able to provide you with more information about the study requirements Participants who qualify for the study will receive the study drug, study-related consultation and care, study visits tests, assessments and procedures at no cost, and may be compensated for their time and travel expenses. Qualifications: - Must be diagnosed with Parkinson’s Disease LESS than 3 years ago - Symptoms have gotten worse since diagnosis - Cannot have previously undergone a surgical procedure for Parkinson's Disease (example: deep brain stimulation) - Cannot have a history of brain tumor, epilepsy, or seizures - In the past year, have you had any hallucinations or episodes of psychosis for which you had to consult with a psychiatrist? (answer NO) - Cannot have had a heart attack in the past year - No cancer in last 5 years
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages: 18+ Gender: All Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost. Additionally, travel costs may be reimbursed, the site will discuss this with you. Study Description: The purpose of this clinical study is to see how effective an investigational topical medication is at helping to treat nerve pain after a surgical procedure - also known as chronic post-surgical neuropathic pain. Post-operative nerve pain is common after many different operations and is normally located around the incision area. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the topical medication being tested in this study (which is currently on the market for use in other indications), or a low dose medication (which looks like the study medication but contains a much lower concentration of the active medication) that is currently not on the market. Both options are an adhesive wearable patch that would be applied to your skin for 60 min at different timepoints during the study. Your total participation will last approximately 10 months and you will be asked to attend several in person visits over the course of the study. During these visits, you will complete various diagnostic and laboratory tests. The medical office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost. Additionally, travel costs may be reimbursed, the site will discuss this with you. - Pain cannot be result of an amputation surgery, back-surgery due to back-pain, or surgery due to nerve compression repair - Pain symptoms must be from the last 6 months - 5 years - Pain scale from be 4 out of 10 - Can be taking opioid medication to manage pain, but study will require you to stop - Cannot currently be part of a lawsuit due to chronic pain or disability
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Have you been diagnosed with psoriatic arthritis (PsA) for 3 months or longer (answer: Yes) - Do you have active plaque psoriasis lesions or a history of plaque psoriasis (answer: Yes) - Have you ever taken medication to treat your PsA? (includes current and past use) (answer: Yes) - Have you ever taken a TNF-alpha inhibitor to treat your PsA? Examples include: - Cimzia (certolizumab) Enbrel (etanercept) Humira (adalimumab) Remicade (infliximab) Simponi (golimumab) (answer: yes or unsure) - Have you been diagnosed with any of the following conditions? - Lupus - Multiple Sclerosis - Rheumatoid Arthritis - Gout - Lyme disease (answer: No) Study Description: The purpose of this clinical study is to see how effective an investigational medication is at helping to treat psoriatic arthritis. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the study medication, a placebo, or an FDA-approved medication (apremilast) to be taken twice daily for four months. After four months, participants receiving the placebo option will be re-assigned to the study drug or apremilast and all participants will continue taking their medication for an additional 8 months. Your total participation will last approximately 14 months and will include regular doctor’s visits for follow-up care and testing. After the initial treatment portion of the study, there will be an opportunity for participants to join an optional open label extension period where they will take the investigational study drug for an additional 2 years. The doctor’s office conducting the study will be able to provide you with more information about the study requirements and the optional open label extension period. Participants who qualify for the study will receive trial-related procedures and study medication (or placebo) at no cost and may be compensated for time and travel.
Conversion Point: Valid Form Fill Ages: 18-70 Gender: Any Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $74 per visit for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must be diagnosed with Systemic Lupus Erythematosus (SLE) for 6 months or longer - Cannot have a history of any of the following: Deep vein thrombosis, Pulmonary embolism, Heart attack, Stroke, or Transient ischemic attack (TIA) or mini-stroke - Must be taking medication to treat your lupus symptoms that could include: Oral Corticosteroids (e.g., prednisone, prednisolone), Anti-malarial agents (e.g., chloroquine, hydroxychloroquine), or Conventional immunosuppressants (e.g., mycophenolate mofetil, azathioprine, calcineurin inhibitors, methotrexate) Study Description: The purpose of the APATURA study is to see how effective an investigational medication is at helping to treat Systemic Lupus Erythematosus (SLE). You may be asked to attend 1 screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive the first dose of medication being tested in this study intravenously (through an IV), then the medication will be given as injections every 2 weeks for 6 months. Your total participation will last approximately 10 months and you will be asked to attend two study visits per month during the treatment period and once per month during the follow-up period. You will have the possibility of performing some of these visits remotely from your home, replacing physical office visits. During these visits, you will complete various diagnostic and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $74 per visit for time and travel. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. Study Details: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat Thyroid Eye Disease (TED) associated with Graves’ Disease or Hashimoto Thyroiditis. Travel support will be provided for participants who live outside of the study site area. You may be asked to attend 1 screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken twice a day for 6 months. After the treatment period, you will continue to be monitored by the study physician for a period of up to two years. Depending on your response to the study drug, you may be given the option to enroll in a follow-up study. There will be 15 study visits where you will complete various procedures and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. The doctor conducting the study will be able to provide you with more information about the study requirements. Qualifications: -Must be diagnosed with either Graves' Disease or Hashimotos Thyroiditis -Experiencing symptoms only for up to a year - not longer - Cannot be diabetic
iS Clinical combines pharmaceutical-grade botanicals with advanced science to deliver clinically proven skincare solutions that cleanse, protect, treat, and rejuvenate for healthier-looking skin.
Who We Are
iS Clinical is dedicated to developing clinically proven, results-driven skincare solutions that bridge the gap between science and beauty. Their formulations are both botanically derived and utilise scientifically advanced ingredients to deliver visible, transformative results. Their range offers multitasking, performance-based products, designed to address a variety of skin concerns—including acne, hyperpigmentation, rosacea, eczema, mild scarring, and signs of aging. With an inclusive approach, their offerings are suitable for all skin types, ages, and conditions, including cancer care and pregnancy-safe options. Trusted by plastic surgeons, dermatologists, skincare professionals, and celebrities worldwide, iS Clinical represents the forefront of innovative, high-performance skincare.
Why Join the iS Clinical Affiliate Program?
Joining the iS Clinical affiliate program offers a compelling opportunity due to the brand's commitment to science-backed, results-driven skincare. iS Clinical is a multi-award-winning brand at the forefront of scientifically advanced skincare, renowned for its exceptional quality and scientifically advanced formulations. Their products are formulated with powerful botanical acids, intelligent peptides, proteins, amino acids, antioxidants, and growth factors, ensuring efficacy and visible improvements in skin tone, texture, and overall health. The brand is also committed to ethical practices, with products being cruelty-free, paraben-free, and largely vegan. This strong foundation in clinical research and high-quality ingredients makes iS Clinical products highly desirable to consumers, leading to strong conversion potential for affiliates.
How do you benefit from the iS Clinical program at Webgains?
Banners: Creatives updated in line with promotions and seasonal events
Data feed: fully automated and updated daily
Commission: earn 8% commission
Cookie Length: 30 days
Free Shipping: On all orders over £95
Who We Are
iS Clinical is dedicated to developing clinically proven, results-driven skincare solutions that bridge the gap between science and beauty. Their formulations are both botanically derived and utilise scientifically advanced ingredients to deliver visible, transformative results. Their range offers multitasking, performance-based products, designed to address a variety of skin concerns—including acne, hyperpigmentation, rosacea, eczema, mild scarring, and signs of aging. With an inclusive approach, their offerings are suitable for all skin types, ages, and conditions, including cancer care and pregnancy-safe options. Trusted by plastic surgeons, dermatologists, skincare professionals, and celebrities worldwide, iS Clinical represents the forefront of innovative, high-performance skincare.
Why Join the iS Clinical Affiliate Program?
Joining the iS Clinical affiliate program offers a compelling opportunity due to the brand's commitment to science-backed, results-driven skincare. iS Clinical is a multi-award-winning brand at the forefront of scientifically advanced skincare, renowned for its exceptional quality and scientifically advanced formulations. Their products are formulated with powerful botanical acids, intelligent peptides, proteins, amino acids, antioxidants, and growth factors, ensuring efficacy and visible improvements in skin tone, texture, and overall health. The brand is also committed to ethical practices, with products being cruelty-free, paraben-free, and largely vegan. This strong foundation in clinical research and high-quality ingredients makes iS Clinical products highly desirable to consumers, leading to strong conversion potential for affiliates.
How do you benefit from the iS Clinical program at Webgains?
Banners: Creatives updated in line with promotions and seasonal events
Data feed: fully automated and updated daily
Commission: earn 8% commission
Cookie Length: 30 days
Free Shipping: On all orders over £95
